Ahmedabad, 18th of November 2026 : Senores Pharmaceuticals Limited has secured Pharmaceutical Inspection Co-operation Scheme (PIC/S) Good Manufacturing Practices (GMP) certification for the manufacturing facility of its subsidiary, Ratnatris Pharmaceuticals Private Limited, in Mehsana, Gujarat. Issued by Ukraine’s State Service on Medicines and Drugs Control (SMDC), the certification expands the company’s pathway to pursue regulatory approvals across semi-regulated pharmaceutical markets.
Commenting on the development, Mr. Swapnil Shah, Managing Director, Senores Pharmaceuticals, said, “The PIC/s approval will open many strategic markets that we couldn’t serve so far. With approval of both, injectable and oral solids, our diverse and strategic portfolio’s reach will be further enhanced, and will continue to give long term growth and sustained profitability”.
The certificate of GMP compliance was issued by SMDC on November 16, 2026, and received by the company on November 17, 2026.

About Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited is a global research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada and other regulated and emerging markets across various therapeutic areas and dosage forms.
The company’s current portfolio includes 64 ANDAs and 19 CMO/CDMO commercial products that are permitted for distribution in the USA. Senores is also engaged in the development and manufacturing of complex generics certified by global food and drugs authorities and delivers generic drugs for emerging markets catering to more than 40 countries. The company currently has approvals from regulatory bodies of more than 10 countries for its manufacturing facility in Chhatral for emerging markets with 558 product registrations and 944 product applications. Senores also manufactures critical care injectables and Active Pharmaceutical Ingredients (API).
Senores has 3 manufacturing facilities for formulations – one in Atlanta, US which is USFDA approved and DEA/BAA compliant, second in Gujarat, which is also US-FDA approved and the third in Chhatral, Ahmedabad, India approved by WHO GMP to cater to Emerging Markets. The company also has 2 manufacturing facilities for API in India, both located around Ahmedabad, with one in Chhatral and the other in Naroda. Senores has strong R&D capabilities to drive differentiated product portfolio across 3 R&D sites (1 in the USA and 2 in India).

More Stories
Industrial AI Startup Countai Raises Rs 10 Crore In Seed Funding Led By Equirus Innovatex Fund.
South Delhi’s Luxury Floor Price Rises By Up To 40% In Q3 2026: Golden Growth Fund.
Ca. Prasanna Kumar D, President, The Institute Of Chartered Accountants Of India, Elected As The Board Member Of The International Federation Of Accountants (IFAC).